What is the next step if a proton‑pump inhibitor (PPI) fails to relieve symptoms?

Management of PPI-Refractory GERD Symptoms

When a PPI fails to control symptoms after 4-8 weeks, first assess compliance and increase to twice-daily dosing or switch to a more potent acid suppressive agent, then reassess at 4-8 weeks before proceeding to objective reflux testing with pH-impedance monitoring. 1

Initial Optimization Strategy

When patients have partial or no response to standard once-daily PPI therapy:

• Verify medication compliance and optimize timing (30-60 minutes before meals) 1
• Increase to twice-daily PPI dosing (though not FDA-approved for most indications) or switch to an alternative PPI with potentially better acid suppression 1
• Reassess response at 4-8 weeks after dose optimization 1

The British Society of Gastroenterology guidelines emphasize that persistent acid exposure on twice-daily PPIs is uncommon, affecting only ~7% of patients with typical reflux symptoms, making dose escalation a logical first step 1

Diagnostic Evaluation for Persistent Symptoms

If symptoms persist despite twice-daily PPI therapy, objective testing becomes essential:

pH-Impedance Monitoring (Preferred)

• Perform 24-hour pH-impedance monitoring ON PPI therapy to determine the mechanism of persistent symptoms in patients with proven GERD 1
• pH-impedance is superior to pH monitoring alone because it detects both acid and non-acid reflux episodes, which is critical since ~60% of PPI-refractory patients have symptomatic non-acid reflux 1
• This testing identifies three key phenotypes: non-erosive reflux disease, reflux hypersensitivity (hypersensitive esophagus), and functional heartburn 1

Alternative: Testing OFF PPI

• Consider prolonged wireless pH monitoring OFF PPI (for multiple days) in patients without prior endoscopy or those needing confirmation of GERD diagnosis 1
• This approach helps distinguish true GERD (AET ≥6.0% on ≥2 days) from borderline GERD (AET ≥4.0% but not meeting full criteria) versus no GERD (AET <4.0% on all days) 1

Phenotype-Directed Adjunctive Therapy

Once the mechanism is identified, personalize treatment to the specific GERD phenotype rather than empirically adding medications 1:

For Breakthrough Acid Reflux:

• Alginate-based antacids for breakthrough symptoms 1
• Nighttime H2 receptor antagonists specifically for nocturnal symptoms 1
• Wedge pillow elevation may be non-inferior to evening PPI for nocturnal reflux and improves sleep quality 2

For Volume Reflux/Regurgitation:

• Baclofen (a GABA-B agonist) reduces transient lower esophageal sphincter relaxations and is particularly effective for regurgitation or belch-predominant symptoms 1, 3

For Coexistent Gastroparesis:

• Prokinetic agents when delayed gastric emptying contributes to symptoms 1

For Reflux Hypersensitivity or Functional Heartburn:

• Pharmacologic neuromodulation (tricyclic antidepressants or SSRIs) to modulate visceral pain perception 1, 3
• Behavioral interventions: cognitive behavioral therapy, gut-directed hypnotherapy, or diaphragmatic breathing exercises 1, 3

Surgical and Endoscopic Options

For patients with confirmed pathologic GERD who fail optimized medical therapy:

Candidacy Requirements:

• Confirmatory evidence of pathologic GERD on objective testing 1
• Exclusion of achalasia via high-resolution manometry 1
• Assessment of esophageal peristaltic function to ensure adequate motility 1

Surgical Options:

• Laparoscopic fundoplication and magnetic sphincter augmentation are effective in carefully selected patients 1
• Transoral incisionless fundoplication is an endoscopic alternative for select cases 1
• Roux-en-Y gastric bypass serves as primary anti-reflux intervention in obese patients or salvage option in non-obese patients 1

Critical caveat: Approximately two-thirds of surgical patients respond, but sleeve gastrectomy may worsen GERD and should be avoided 1, 3

Common Pitfalls to Avoid

• Do not continue empiric PPI escalation indefinitely without objective testing—this leads to unnecessary medication exposure and missed alternative diagnoses 1
• Do not perform pH monitoring alone in PPI-refractory patients; pH-impedance is essential to detect non-acid reflux 1
• Do not proceed to surgery without comprehensive workup including manometry to exclude achalasia and assess peristaltic function 1
• Recognize that up to 40% of "GERD" patients may have functional disorders (functional heartburn, functional dyspepsia) that will not respond to acid suppression and require neuromodulation instead 3, 4